SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

RBC Capital Maintains Sector Perform on Biogen, Lowers Price Target to $273

RBC Capital analyst Brian Abrahams maintains Biogen (NASDAQ:BIIB) with a Sector Perform and lowers the price target from $303 to $273.

Benzinga · -
RBC Capital analyst Brian Abrahams maintains Biogen (NASDAQ: BIIB) with a Sector Perform and lowers the price target from $303 to $273.